| Dr Louis J Arno, MD | |
|
3322 Route 22 Ste 605, Branchburg, NJ 08876-4401 | |
| (908) 428-7530 | |
| (908) 428-7529 |
| Full Name | Dr Louis J Arno |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 38 Years |
| Location | 3322 Route 22 Ste 605, Branchburg, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720185978 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hunterdon Medical Center | Flemington, NJ | Hospital |
| Robert Wood Johnson University Hospital - Somerset | Somerville, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hunterdon Specialty Care Pc | 4587966601 | 83 |
News Archive
In an analysis that included more than 70,000 participants from 13 studies, subclinical hyperthyroidism was associated with an increased risk for hip and other fractures including spine, according to a study in the May 26 issue of JAMA. Subclinical hyperthyroidism is a low serum thyroid-stimulating hormone concentration in a person without clinical symptoms and normal thyroid hormone concentrations on blood tests.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
In view of World Humanitarian Day, a Huffington Post blog discusses the "lessons" of disaster response and the global "proliferation of humanitarian crises." First, the authors write that "the number of people affected by disasters is on the rise," mostly due to conflict and natural disasters. "Second, and in spite of these trends, U.S. humanitarian assistance is a sound investment. Though only about one-tenth of one percent of the federal budget, our aid not only saves lives, but promotes security and well-being where despair and misery threaten."
› Verified 3 days ago
| Entity Name | Hunterdon Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306216874 PECOS PAC ID: 4587966601 Enrollment ID: O20160106002688 |
News Archive
In an analysis that included more than 70,000 participants from 13 studies, subclinical hyperthyroidism was associated with an increased risk for hip and other fractures including spine, according to a study in the May 26 issue of JAMA. Subclinical hyperthyroidism is a low serum thyroid-stimulating hormone concentration in a person without clinical symptoms and normal thyroid hormone concentrations on blood tests.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
In view of World Humanitarian Day, a Huffington Post blog discusses the "lessons" of disaster response and the global "proliferation of humanitarian crises." First, the authors write that "the number of people affected by disasters is on the rise," mostly due to conflict and natural disasters. "Second, and in spite of these trends, U.S. humanitarian assistance is a sound investment. Though only about one-tenth of one percent of the federal budget, our aid not only saves lives, but promotes security and well-being where despair and misery threaten."
› Verified 3 days ago
| Entity Name | Louis J. Arno Md. Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689148199 PECOS PAC ID: 5698012060 Enrollment ID: O20190123001172 |
News Archive
In an analysis that included more than 70,000 participants from 13 studies, subclinical hyperthyroidism was associated with an increased risk for hip and other fractures including spine, according to a study in the May 26 issue of JAMA. Subclinical hyperthyroidism is a low serum thyroid-stimulating hormone concentration in a person without clinical symptoms and normal thyroid hormone concentrations on blood tests.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
In view of World Humanitarian Day, a Huffington Post blog discusses the "lessons" of disaster response and the global "proliferation of humanitarian crises." First, the authors write that "the number of people affected by disasters is on the rise," mostly due to conflict and natural disasters. "Second, and in spite of these trends, U.S. humanitarian assistance is a sound investment. Though only about one-tenth of one percent of the federal budget, our aid not only saves lives, but promotes security and well-being where despair and misery threaten."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Louis J Arno, MD 3322 Route 22 Ste 605, Branchburg, NJ 08876-4401 Ph: (908) 428-7530 | Dr Louis J Arno, MD 3322 Route 22 Ste 605, Branchburg, NJ 08876-4401 Ph: (908) 428-7530 |
News Archive
In an analysis that included more than 70,000 participants from 13 studies, subclinical hyperthyroidism was associated with an increased risk for hip and other fractures including spine, according to a study in the May 26 issue of JAMA. Subclinical hyperthyroidism is a low serum thyroid-stimulating hormone concentration in a person without clinical symptoms and normal thyroid hormone concentrations on blood tests.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
In view of World Humanitarian Day, a Huffington Post blog discusses the "lessons" of disaster response and the global "proliferation of humanitarian crises." First, the authors write that "the number of people affected by disasters is on the rise," mostly due to conflict and natural disasters. "Second, and in spite of these trends, U.S. humanitarian assistance is a sound investment. Though only about one-tenth of one percent of the federal budget, our aid not only saves lives, but promotes security and well-being where despair and misery threaten."
› Verified 3 days ago
Ramon Rego, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3322 Route 22, Bldg #1, Branchburg, NJ 08876 Phone: 908-704-0100 Fax: 908-704-2237 | |
Dr. Patrick F Saulino, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3322 Route 22, Suite 505, Branchburg, NJ 08876 Phone: 908-231-0041 Fax: 908-231-0048 | |
Dr. Vasanthi Kachirayan, M.D., Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3322 Us Highway 22, Suite 806, Branchburg, NJ 08876 Phone: 908-231-9900 | |
Dr. Romeo Anthony Caballes Jr., M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9 Lamington Rd, Suite B, Branchburg, NJ 08876 Phone: 908-203-0022 Fax: 908-203-0122 |